Filing Details
- Accession Number:
- 0001415889-25-008558
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-18 21:30:09
- Reporting Period:
- 2025-03-15
- Filing Date:
- 2025-03-18
- Accepted Time:
- 2025-03-18 21:30:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1759425 | Mirum Pharmaceuticals Inc. | MIRM | Pharmaceutical Preparations (2834) | 831281555 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1974200 | Jolanda Howe | C/O Mirum Pharmaceuticals, Inc. 989 E Hillsdale Blvd., Suite 300 Foster City CA 94404 | Svp, Global Controller | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-15 | 5,315 | $0.00 | 9,547 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-03-17 | 2,900 | $44.21 | 6,647 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-03-17 | 52,900 | $2.94 | 59,547 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-03-17 | 50,111 | $44.33 | 9,436 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-17 | 2,789 | $44.75 | 6,647 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-03-17 | 1,806 | $44.36 | 4,841 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Restricted Stock Units | Disposition | 2025-03-15 | 5,315 | $0.00 | 5,315 | $0.00 |
| Common Stock | Stock Option (right to buy) | Disposition | 2025-03-17 | 52,900 | $0.00 | 52,900 | $2.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,658 | No | 4 | M | Direct | ||
| 0 | 2029-03-11 | No | 4 | M | Direct |
Footnotes
- Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- Shares sold to cover tax withholding obligations associated with the vesting of the performance restricted stock units.
- Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 16, 2024.
- The weighted average sale price for the transaction reported was $44.33410, and the range of prices were between $43.695 and $44.695. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- The weighted average sale price for the transaction reported was $44.74811, and the range of prices were between $44.70 and $44.84. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- The weighted average sale price for the transaction reported was $44.35923, and the range of prices were between $43.81 and $44.71. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026.
- The stock option is fully vested.
Billionaire Hedge Funds
